{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:40:53Z","timestamp":1789692053135,"version":"4.0.1"},"reference-count":115,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T00:00:00Z","timestamp":1721001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T00:00:00Z","timestamp":1721001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI20-00716"],"award-info":[{"award-number":["PI20-00716"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI20-00784"],"award-info":[{"award-number":["PI20-00784"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023731","name":"Consejer\u00eda de Salud y Consumo, Junta de Andaluc\u00eda","doi-asserted-by":"publisher","award":["PI0026-2017"],"award-info":[{"award-number":["PI0026-2017"]}],"id":[{"id":"10.13039\/501100023731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023731","name":"Consejer\u00eda de Salud y Consumo, Junta de Andaluc\u00eda","doi-asserted-by":"publisher","award":["PI20-00932"],"award-info":[{"award-number":["PI20-00932"]}],"id":[{"id":"10.13039\/501100023731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","award":["PID2022-137080OB-I00"],"award-info":[{"award-number":["PID2022-137080OB-I00"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100024571","name":"Novo Nordisk Foundation Center for Protein Research, University of Copenhagen","doi-asserted-by":"publisher","award":["NNF14CC0001"],"award-info":[{"award-number":["NNF14CC0001"]}],"id":[{"id":"10.13039\/501100024571","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018703","name":"HORIZON EUROPE European Innovation Council","doi-asserted-by":"publisher","award":["EPICS-XS-823839"],"award-info":[{"award-number":["EPICS-XS-823839"]}],"id":[{"id":"10.13039\/100018703","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Biomed Sci"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Critical limb-threatening ischemia (CLTI) constitutes the most severe manifestation of peripheral artery disease, usually induced by atherosclerosis. CLTI patients suffer from high risk of amputation of the lower extremities and elevated mortality rates, while they have low options for surgical revascularization due to associated comorbidities. Alternatively, cell-based therapeutic strategies represent an effective and safe approach to promote revascularization. However, the variability seen in several factors such as cell combinations or doses applied, have limited their success in clinical trials, being necessary to reach a consensus regarding the optimal \u201ccellular-cocktail\u201d prior further application into the clinic. To achieve so, it is essential to understand the mechanisms by which these cells exert their regenerative properties.<\/jats:p>\n                <jats:p>Herein, we have evaluated, for the first time, the regenerative and vasculogenic potential of a combination of endothelial colony forming cells (ECFCs) and mesenchymal stem cells (MSCs) isolated from adipose-tissue (AT), compared with ECFCs from umbilical cord blood (CB-ECFCs) and AT-MSCs, in a murine model of CLTI.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Balb-c nude mice (n:32) were distributed in four different groups (n:8\/group): control shams, and ischemic mice (after femoral ligation) that received 50\u00a0\u00b5l of physiological serum alone or a cellular combination of AT-MSCs with either CB-ECFCs or AT-ECFCs. Follow-up of blood flow reperfusion and ischemic symptoms was carried out for 21\u00a0days, when mice were sacrificed to evaluate vascular density formation. Moreover, the long-term molecular changes in response to CLTI and both cell combinations were analyzed in a proteomic quantitative approach.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>AT-MSCs with either AT- or CB-ECFCs, promoted a significant recovery of blood flow in CLTI mice 21\u00a0days post-ischemia. Besides, they modulated the inflammatory and necrotic related processes, although the CB group presented the slowest ischemic progression along the assay. Moreover, many proteins involved in the repairing mechanisms promoted by cell treatments were identified.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The combination of AT-MSCs with AT-ECFCs or with CB-ECFCs promoted similar revascularization in CLTI mice, by restoring blood flow levels, together with the modulation of the inflammatory and necrotic processes, and reduction of muscle damage. The protein changes identified are representative of the molecular mechanisms involved in ECFCs and MSCs-induced revascularization (immune response, vascular repair, muscle regeneration, etc.).<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12929-024-01059-w","type":"journal-article","created":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T03:08:44Z","timestamp":1721012924000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Unraveling the differential mechanisms of revascularization promoted by MSCs &amp; ECFCs from adipose tissue or umbilical cord in a murine model of critical limb-threatening ischemia"],"prefix":"10.1186","volume":"31","author":[{"given":"Marta","family":"Rojas-Torres","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc\u00eda","family":"Beltr\u00e1n-Camacho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Mart\u00ednez-Val","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ismael","family":"S\u00e1nchez-Gomar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Eslava-Alc\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Rosal-Vela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarita","family":"Jim\u00e9nez-Palomares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Doiz-Art\u00e1zcoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Mart\u00ednez-Torija","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Moreno-Luna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesper V.","family":"Olsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3954-3734","authenticated-orcid":false,"given":"Ma. Carmen","family":"Duran-Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,15]]},"reference":[{"issue":"1","key":"1059_CR1","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.jvs.2012.03.255","volume":"56","author":"RJ Powell","year":"2012","unstructured":"Powell RJ. Update on clinical trials evaluating the effect of biologic therapy in patients with critical limb ischemia. J Vasc Surg. 2012;56(1):264\u20136.","journal-title":"J Vasc Surg"},{"key":"1059_CR2","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1016\/j.jvs.2023.01.200","volume":"77","author":"M Kwong","year":"2023","unstructured":"Kwong M, et al. Updated estimates for the burden of chronic limb-threatening ischemia in the Medicare population. J Vasc Surg. 2023;77:1760\u201375.","journal-title":"J Vasc Surg"},{"issue":"9","key":"1059_CR3","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1161\/CIRCRESAHA.115.303565","volume":"116","author":"JP Cooke","year":"2015","unstructured":"Cooke JP, Losordo DW. Modulating the vascular response to limb ischemia: angiogenic and cell therapies. Circ Res. 2015;116(9):1561\u201378.","journal-title":"Circ Res"},{"issue":"1","key":"1059_CR4","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s13287-020-02110-x","volume":"12","author":"P Nammian","year":"2021","unstructured":"Nammian P, et al. Comparative analysis of mouse bone marrow and adipose tissue mesenchymal stem cells for critical limb ischemia cell therapy. Stem Cell Res Ther. 2021;12(1):58.","journal-title":"Stem Cell Res Ther"},{"key":"1059_CR5","doi-asserted-by":"publisher","first-page":"602837","DOI":"10.3389\/fcell.2020.602837","volume":"8","author":"M Rojas-Torres","year":"2020","unstructured":"Rojas-Torres M, et al. REX-001, a BM-MNC Enriched Solution, Induces Revascularization of Ischemic Tissues in a Murine Model of Chronic Limb-Threatening Ischemia. Front Cell Dev Biol. 2020;8:602837.","journal-title":"Front Cell Dev Biol"},{"issue":"15","key":"1059_CR6","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1093\/eurheartj\/ehv006","volume":"36","author":"H Reinecke","year":"2015","unstructured":"Reinecke H, et al. Peripheral arterial disease and critical limb ischaemia: still poor outcomes and lack of guideline adherence. Eur Heart J. 2015;36(15):932\u20138.","journal-title":"Eur Heart J"},{"issue":"13","key":"1059_CR7","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1161\/CIR.0b013e31828b82aa","volume":"127","author":"JL Anderson","year":"2013","unstructured":"Anderson JL, et al. Management of patients with peripheral artery disease (compilation of 2005 and 2011 ACCF\/AHA guideline recommendations): a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines. Circulation. 2013;127(13):1425\u201343.","journal-title":"Circulation"},{"issue":"5","key":"1059_CR8","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.3390\/ijms22052335","volume":"22","author":"L Beltran-Camacho","year":"2021","unstructured":"Beltran-Camacho L, Rojas-Torres M, Duran-Ruiz MC. Current Status of Angiogenic Cell Therapy and Related Strategies Applied in Critical Limb Ischemia. Int J Mol Sci. 2021;22(5):2335.","journal-title":"Int J Mol Sci"},{"issue":"9331","key":"1059_CR9","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/S0140-6736(02)09670-8","volume":"360","author":"E Tateishi-Yuyama","year":"2002","unstructured":"Tateishi-Yuyama E, et al. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet. 2002;360(9331):427\u201335.","journal-title":"Lancet"},{"issue":"11","key":"1059_CR10","doi-asserted-by":"publisher","first-page":"5015","DOI":"10.7150\/thno.74785","volume":"12","author":"JX Han","year":"2022","unstructured":"Han JX, et al. Therapeutic angiogenesis-based strategy for peripheral artery disease. Theranostics. 2022;12(11):5015\u201333.","journal-title":"Theranostics"},{"issue":"9","key":"1059_CR11","doi-asserted-by":"publisher","first-page":"2410","DOI":"10.1182\/blood.V83.9.2410.2410","volume":"83","author":"H Mayani","year":"1994","unstructured":"Mayani H, Lansdorp PM. Thy-1 Expression Is Linked to Functional-Properties of Primitive Hematopoietic Progenitor Cells from Human Umbilical-Cord Blood. Blood. 1994;83(9):2410\u20137.","journal-title":"Blood"},{"key":"1059_CR12","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.ijcard.2015.10.110","volume":"203","author":"SW Kim","year":"2016","unstructured":"Kim SW, et al. Therapeutic effects of late outgrowth endothelial progenitor cells or mesenchymal stem cells derived from human umbilical cord blood on infarct repair. Int J Cardiol. 2016;203:498\u2013507.","journal-title":"Int J Cardiol"},{"issue":"2","key":"1059_CR13","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.avsg.2007.07.037","volume":"22","author":"H Zhang","year":"2008","unstructured":"Zhang H, et al. Therapeutic angiogenesis of bone marrow mononuclear cells (MNCs) and peripheral blood MNCs: transplantation for ischemic hindlimb. Ann Vasc Surg. 2008;22(2):238\u201347.","journal-title":"Ann Vasc Surg"},{"issue":"21","key":"1059_CR14","doi-asserted-by":"publisher","first-page":"7887","DOI":"10.3390\/ijms21217887","volume":"21","author":"YC Chen","year":"2020","unstructured":"Chen YC, et al. Circulatory Rejuvenated EPCs Derived from PAOD Patients Treated by CD34(+) Cells and Hyperbaric Oxygen Therapy Salvaged the Nude Mouse Limb against Critical Ischemia. Int J Mol Sci. 2020;21(21):7887.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1059_CR15","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.diabres.2010.12.010","volume":"92","author":"D Lu","year":"2011","unstructured":"Lu D, et al. Comparison of bone marrow mesenchymal stem cells with bone marrow-derived mononuclear cells for treatment of diabetic critical limb ischemia and foot ulcer: a double-blind, randomized, controlled trial. Diabetes Res Clin Pract. 2011;92(1):26\u201336.","journal-title":"Diabetes Res Clin Pract"},{"issue":"5","key":"1059_CR16","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1089\/ten.teb.2016.0050","volume":"22","author":"D Tasev","year":"2016","unstructured":"Tasev D, Koolwijk P, van Hinsbergh VW. Therapeutic Potential of Human-Derived Endothelial Colony-Forming Cells in Animal Models. Tissue Eng Part B Rev. 2016;22(5):371\u201382.","journal-title":"Tissue Eng Part B Rev"},{"issue":"11","key":"1059_CR17","doi-asserted-by":"publisher","first-page":"4761","DOI":"10.1182\/blood-2006-12-062471","volume":"109","author":"JM Melero-Martin","year":"2007","unstructured":"Melero-Martin JM, et al. In vivo vasculogenic potential of human blood-derived endothelial progenitor cells. Blood. 2007;109(11):4761\u20138.","journal-title":"Blood"},{"issue":"1","key":"1059_CR18","doi-asserted-by":"publisher","first-page":"e55592","DOI":"10.1371\/journal.pone.0055592","volume":"8","author":"M Teraa","year":"2013","unstructured":"Teraa M, et al. Bone marrow alterations and lower endothelial progenitor cell numbers in critical limb ischemia patients. PLoS ONE. 2013;8(1):e55592.","journal-title":"PLoS ONE"},{"issue":"1","key":"1059_CR19","doi-asserted-by":"publisher","first-page":"13558","DOI":"10.1038\/s41598-017-13971-3","volume":"7","author":"A Shafiee","year":"2017","unstructured":"Shafiee A, et al. Mesenchymal stem\/stromal cells enhance engraftment, vasculogenic and pro-angiogenic activities of endothelial colony forming cells in immunocompetent hosts. Sci Rep. 2017;7(1):13558.","journal-title":"Sci Rep"},{"issue":"9","key":"1059_CR20","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.3727\/096368910X504487","volume":"19","author":"V Vanneaux","year":"2010","unstructured":"Vanneaux V, et al. In vitro and in vivo analysis of endothelial progenitor cells from cryopreserved umbilical cord blood: are we ready for clinical application? Cell Transplant. 2010;19(9):1143\u201355.","journal-title":"Cell Transplant"},{"issue":"2","key":"1059_CR21","doi-asserted-by":"publisher","first-page":"e13","DOI":"10.1161\/ATVBAHA.111.239822","volume":"32","author":"TM Schwarz","year":"2012","unstructured":"Schwarz TM, et al. Vascular incorporation of endothelial colony-forming cells is essential for functional recovery of murine ischemic tissue following cell therapy. Arterioscler Thromb Vasc Biol. 2012;32(2):e13-21.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"1059_CR22","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1007\/s10456-013-9350-0","volume":"16","author":"RZ Lin","year":"2013","unstructured":"Lin RZ, et al. Human white adipose tissue vasculature contains endothelial colony-forming cells with robust in vivo vasculogenic potential. Angiogenesis. 2013;16(4):735\u201344.","journal-title":"Angiogenesis"},{"issue":"28","key":"1059_CR23","doi-asserted-by":"publisher","first-page":"10137","DOI":"10.1073\/pnas.1405388111","volume":"111","author":"RZ Lin","year":"2014","unstructured":"Lin RZ, et al. Human endothelial colony-forming cells serve as trophic mediators for mesenchymal stem cell engraftment via paracrine signaling. Proc Natl Acad Sci U S A. 2014;111(28):10137\u201342.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"1059_CR24","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1161\/CIRCRESAHA.108.178590","volume":"103","author":"JM Melero-Martin","year":"2008","unstructured":"Melero-Martin JM, et al. Engineering robust and functional vascular networks in vivo with human adult and cord blood-derived progenitor cells. Circ Res. 2008;103(2):194\u2013202.","journal-title":"Circ Res"},{"issue":"3","key":"1059_CR25","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.jpeds.2013.10.063","volume":"164","author":"R Moreno-Luna","year":"2014","unstructured":"Moreno-Luna R, et al. Maternal body-mass index and cord blood circulating endothelial colony-forming cells. J Pediatr. 2014;164(3):566\u201371.","journal-title":"J Pediatr"},{"issue":"15","key":"1059_CR26","doi-asserted-by":"publisher","first-page":"5256","DOI":"10.3390\/ijms21155256","volume":"21","author":"S Eslava-Alcon","year":"2020","unstructured":"Eslava-Alcon S, et al. Atherosclerotic Pre-Conditioning Affects the Paracrine Role of Circulating Angiogenic Cells Ex-Vivo. Int J Mol Sci. 2020;21(15):5256.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1059_CR27","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1186\/s13287-022-02943-8","volume":"13","author":"M Rojas-Torres","year":"2022","unstructured":"Rojas-Torres M, et al. Assessment of endothelial colony forming cells delivery routes in a murine model of critical limb threatening ischemia using an optimized cell tracking approach. Stem Cell Res Ther. 2022;13(1):266.","journal-title":"Stem Cell Res Ther"},{"issue":"6","key":"1059_CR28","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.7150\/ijbs.78864","volume":"19","author":"L Beltran-Camacho","year":"2023","unstructured":"Beltran-Camacho L, et al. Cardiovascular-related proteomic changes in ECFCs exposed to the serum of COVID-19 patients. Int J Biol Sci. 2023;19(6):1664\u201380.","journal-title":"Int J Biol Sci"},{"issue":"1","key":"1059_CR29","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s13287-020-01591-0","volume":"11","author":"L Beltran-Camacho","year":"2020","unstructured":"Beltran-Camacho L, et al. Identification of the initial molecular changes in response to circulating angiogenic cells-mediated therapy in critical limb ischemia. Stem Cell Res Ther. 2020;11(1):106.","journal-title":"Stem Cell Res Ther"},{"issue":"9","key":"1059_CR30","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.3390\/biomedicines9091147","volume":"9","author":"L Beltran-Camacho","year":"2021","unstructured":"Beltran-Camacho L, et al. Long Term Response to Circulating Angiogenic Cells, Unstimulated or Atherosclerotic Pre-Conditioned, in Critical Limb Ischemic Mice. Biomedicines. 2021;9(9):1147.","journal-title":"Biomedicines"},{"key":"1059_CR31","first-page":"e1035","volume":"23","author":"H Niiyama","year":"2009","unstructured":"Niiyama H, et al. Murine model of hindlimb ischemia. J Vis Exp. 2009;23:e1035.","journal-title":"J Vis Exp"},{"issue":"5","key":"1059_CR32","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1001\/archneurpsyc.1954.02320410050004","volume":"71","author":"IM Tarlov","year":"1954","unstructured":"Tarlov IM. Spinal cord compression studie. III. Time limits for recovery after gradual compression in dogs. AMA Arch Neurol Psychiatry. 1954;71(5):588\u201397.","journal-title":"AMA Arch Neurol Psychiatry"},{"issue":"6","key":"1059_CR33","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1016\/j.jvs.2012.04.067","volume":"56","author":"RA Brenes","year":"2012","unstructured":"Brenes RA, et al. Toward a mouse model of hind limb ischemia to test therapeutic angiogenesis. J Vasc Surg. 2012;56(6):1669\u201379 discussion 1679.","journal-title":"J Vasc Surg"},{"issue":"4","key":"1059_CR34","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1074\/mcp.TIR119.001906","volume":"19","author":"DB Bekker-Jensen","year":"2020","unstructured":"Bekker-Jensen DB, et al. A Compact Quadrupole-Orbitrap Mass Spectrometer with FAIMS Interface Improves Proteome Coverage in Short LC Gradients. Mol Cell Proteomics. 2020;19(4):716\u201329.","journal-title":"Mol Cell Proteomics"},{"issue":"12","key":"1059_CR35","doi-asserted-by":"publisher","first-page":"e9021","DOI":"10.15252\/msb.20199021","volume":"15","author":"M Leutert","year":"2019","unstructured":"Leutert M, et al. R2\u2013P2 rapid-robotic phosphoproteomics enables multidimensional cell signaling studies. Mol Syst Biol. 2019;15(12):e9021.","journal-title":"Mol Syst Biol"},{"issue":"9","key":"1059_CR36","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/nmeth.3901","volume":"13","author":"S Tyanova","year":"2016","unstructured":"Tyanova S, et al. The Perseus computational platform for comprehensive analysis of (prote)omics data. Nat Methods. 2016;13(9):731\u201340.","journal-title":"Nat Methods"},{"issue":"1","key":"1059_CR37","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1093\/bioinformatics\/btw580","volume":"33","author":"S Wieczorek","year":"2017","unstructured":"Wieczorek S, et al. DAPAR & ProStaR: software to perform statistical analyses in quantitative discovery proteomics. Bioinformatics. 2017;33(1):135\u20136.","journal-title":"Bioinformatics"},{"issue":"14","key":"1059_CR38","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1016\/j.cell.2022.06.003","volume":"185","author":"BR Stockwell","year":"2022","unstructured":"Stockwell BR. Ferroptosis turns 10: Emerging mechanisms, physiological functions, and therapeutic applications. Cell. 2022;185(14):2401\u201321.","journal-title":"Cell"},{"issue":"10","key":"1059_CR39","doi-asserted-by":"publisher","first-page":"3411","DOI":"10.1016\/j.celrep.2020.02.049","volume":"30","author":"H Feng","year":"2020","unstructured":"Feng H, et al. Transferrin Receptor Is a Specific Ferroptosis Marker. Cell Rep. 2020;30(10):3411-3423.e7.","journal-title":"Cell Rep"},{"key":"1059_CR40","doi-asserted-by":"publisher","first-page":"1051866","DOI":"10.3389\/fmolb.2022.1051866","volume":"9","author":"Y Wang","year":"2022","unstructured":"Wang Y, et al. Ferroptosis and its role in skeletal muscle diseases. Front Mol Biosci. 2022;9:1051866.","journal-title":"Front Mol Biosci"},{"key":"1059_CR41","doi-asserted-by":"publisher","first-page":"114630","DOI":"10.1016\/j.expneurol.2023.114630","volume":"372","author":"X Hu","year":"2024","unstructured":"Hu X, et al. The role of ferroptosis and its mechanism in ischemic stroke. Exp Neurol. 2024;372:114630.","journal-title":"Exp Neurol"},{"issue":"1","key":"1059_CR42","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1186\/s13287-021-02330-9","volume":"12","author":"C Thej","year":"2021","unstructured":"Thej C, et al. Human bone marrow-derived, pooled, allogeneic mesenchymal stromal cells manufactured from multiple donors at different times show comparable biological functions in vitro, and in vivo to repair limb ischemia. Stem Cell Res Ther. 2021;12(1):279.","journal-title":"Stem Cell Res Ther"},{"issue":"4","key":"1059_CR43","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.jcyt.2018.12.007","volume":"21","author":"JS Park","year":"2019","unstructured":"Park JS, et al. Enrichment of vascular endothelial growth factor secreting mesenchymal stromal cells enhances therapeutic angiogenesis in a mouse model of hind limb ischemia. Cytotherapy. 2019;21(4):433\u201343.","journal-title":"Cytotherapy"},{"key":"1059_CR44","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/1479-5876-11-143","volume":"11","author":"PK Gupta","year":"2013","unstructured":"Gupta PK, et al. A double blind randomized placebo controlled phase I\/II study assessing the safety and efficacy of allogeneic bone marrow derived mesenchymal stem cell in critical limb ischemia. J Transl Med. 2013;11:143.","journal-title":"J Transl Med"},{"issue":"1","key":"1059_CR45","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s13287-023-03292-w","volume":"14","author":"PK Gupta","year":"2023","unstructured":"Gupta PK, et al. Label extension, single-arm, phase III study shows efficacy and safety of stempeucel(R) in patients with critical limb ischemia due to atherosclerotic peripheral arterial disease. Stem Cell Res Ther. 2023;14(1):60.","journal-title":"Stem Cell Res Ther"},{"issue":"2","key":"1059_CR46","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1002\/stem.2751","volume":"36","author":"M Qadura","year":"2018","unstructured":"Qadura M, et al. Concise Review: Cell Therapy for Critical Limb Ischemia: An Integrated Review of Preclinical and Clinical Studies. Stem Cells. 2018;36(2):161\u201371.","journal-title":"Stem Cells"},{"issue":"8","key":"1059_CR47","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1161\/CIRCRESAHA.116.309045","volume":"120","author":"M Rigato","year":"2017","unstructured":"Rigato M, Monami M, Fadini GP. Autologous Cell Therapy for Peripheral Arterial Disease: Systematic Review and Meta-Analysis of Randomized, Nonrandomized, and Noncontrolled Studies. Circ Res. 2017;120(8):1326\u201340.","journal-title":"Circ Res"},{"issue":"1","key":"1059_CR48","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1186\/s13287-023-03435-z","volume":"14","author":"YC Song","year":"2023","unstructured":"Song YC, et al. Hybrid spheroids containing mesenchymal stem cells promote therapeutic angiogenesis by increasing engraftment of co-transplanted endothelial colony-forming cells in vivo. Stem Cell Res Ther. 2023;14(1):193.","journal-title":"Stem Cell Res Ther"},{"issue":"10","key":"1059_CR49","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1160\/TH17-01-0007","volume":"117","author":"E Rossi","year":"2017","unstructured":"Rossi E, et al. Co-injection of mesenchymal stem cells with endothelial progenitor cells accelerates muscle recovery in hind limb ischemia through an endoglin-dependent mechanism. Thromb Haemost. 2017;117(10):1908\u201318.","journal-title":"Thromb Haemost"},{"issue":"9","key":"1059_CR50","doi-asserted-by":"publisher","first-page":"2752","DOI":"10.1182\/blood-2004-04-1396","volume":"104","author":"DA Ingram","year":"2004","unstructured":"Ingram DA, et al. Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Blood. 2004;104(9):2752\u201360.","journal-title":"Blood"},{"issue":"5","key":"1059_CR51","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1182\/blood-2006-08-043471","volume":"109","author":"MC Yoder","year":"2007","unstructured":"Yoder MC, et al. Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem\/progenitor cell principals. Blood. 2007;109(5):1801\u20139.","journal-title":"Blood"},{"issue":"9","key":"1059_CR52","doi-asserted-by":"publisher","first-page":"844","DOI":"10.7603\/s40730-016-0046-0","volume":"3","author":"NB Vu","year":"2016","unstructured":"Vu NB, et al. Adipose derived stem cell transplantation is better than bone marrow mesenchymal stem cell transplantation in treating hindlimb ischemia in mice. Biomedical Res Ther. 2016;3(9):844\u201356.","journal-title":"Biomedical Res Ther"},{"issue":"1\u20132","key":"1059_CR53","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1023\/A:1023403928385","volume":"246","author":"D Scholz","year":"2003","unstructured":"Scholz D, et al. Angiogenesis and myogenesis as two facets of inflammatory post-ischemic tissue regeneration. Mol Cell Biochem. 2003;246(1\u20132):57\u201367.","journal-title":"Mol Cell Biochem"},{"issue":"4","key":"1059_CR54","doi-asserted-by":"publisher","first-page":"R1693","DOI":"10.1152\/ajpregu.00892.2006","volume":"293","author":"N Dehne","year":"2007","unstructured":"Dehne N, et al. The HIF-1 response to simulated ischemia in mouse skeletal muscle cells neither enhances glycolysis nor prevents myotube cell death. Am J Physiol Regul Integr Comp Physiol. 2007;293(4):R1693\u2013701.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"1059_CR55","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/j.1749-6632.2012.06497.x","volume":"1254","author":"PR Moreno","year":"2012","unstructured":"Moreno PR, Purushothaman M, Purushothaman KR. Plaque neovascularization: defense mechanisms, betrayal, or a war in progress. Ann N Y Acad Sci. 2012;1254:7\u201317.","journal-title":"Ann N Y Acad Sci"},{"issue":"6","key":"1059_CR56","first-page":"1241","volume":"114","author":"M Economopoulou","year":"2015","unstructured":"Economopoulou M, et al. Endothelial-specific deficiency of Junctional Adhesion Molecule-C promotes vessel normalisation in proliferative retinopathy. Thromb Haemost. 2015;114(6):1241\u20139.","journal-title":"Thromb Haemost"},{"issue":"1","key":"1059_CR57","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1038\/s41598-017-00809-1","volume":"7","author":"KT Kang","year":"2017","unstructured":"Kang KT, et al. Endothelial colony forming cells and mesenchymal progenitor cells form blood vessels and increase blood flow in ischemic muscle. Sci Rep. 2017;7(1):770.","journal-title":"Sci Rep"},{"issue":"8","key":"1059_CR58","first-page":"E36","volume":"35","author":"TM Schwarz","year":"2015","unstructured":"Schwarz TM. Vascular Incorporation of Endothelial Colony-Forming Cells Is Essential for Functional Recovery of Murine Ischemic Tissue Following Cell Therapy (vol 32, pg e13, 2012). Arterioscler Thromb Vasc Biol. 2015;35(8):E36\u2013E36.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"12","key":"1059_CR59","doi-asserted-by":"publisher","first-page":"2757","DOI":"10.1681\/ASN.2019050508","volume":"31","author":"O Pleniceanu","year":"2020","unstructured":"Pleniceanu O, et al. Successful Introduction of Human Renovascular Units into the Mammalian Kidney. J Am Soc Nephrol. 2020;31(12):2757\u201372.","journal-title":"J Am Soc Nephrol"},{"key":"1059_CR60","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s13287-019-1157-5","volume":"10","author":"I Meivar-Levy","year":"2019","unstructured":"Meivar-Levy I, et al. The role of the vasculature niche on insulin-producing cells generated by transdifferentiation of adult human liver cells. Stem Cell Res Ther. 2019;10:53.","journal-title":"Stem Cell Res Ther"},{"key":"1059_CR61","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.biomaterials.2015.05.002","volume":"60","author":"G Odent Grigorescu","year":"2015","unstructured":"Odent Grigorescu G, et al. Combinatorial approach for improving the outcome of angiogenic therapy in ischemic tissues. Biomaterials. 2015;60:72\u201381.","journal-title":"Biomaterials"},{"issue":"3","key":"1059_CR62","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1007\/s10456-014-9423-8","volume":"17","author":"MR Richardson","year":"2014","unstructured":"Richardson MR, et al. Angiopoietin-like protein 2 regulates endothelial colony forming cell vasculogenesis. Angiogenesis. 2014;17(3):675\u201383.","journal-title":"Angiogenesis"},{"issue":"2","key":"1059_CR63","doi-asserted-by":"publisher","first-page":"431","DOI":"10.3390\/ijms19020431","volume":"19","author":"C Carbone","year":"2018","unstructured":"Carbone C, et al. Angiopoietin-Like Proteins in Angiogenesis, Inflammation and Cancer. Int J Mol Sci. 2018;19(2):431.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"1059_CR64","doi-asserted-by":"publisher","first-page":"e000201","DOI":"10.1161\/JAHA.113.000201","volume":"2","author":"N Farhat","year":"2013","unstructured":"Farhat N, et al. Angiopoietin-Like 2 Promotes Atherogenesis in Mice. J Am Heart Assoc. 2013;2(3):e000201.","journal-title":"J Am Heart Assoc"},{"key":"1059_CR65","doi-asserted-by":"publisher","first-page":"111667","DOI":"10.1016\/j.biopha.2021.111667","volume":"139","author":"ZH He","year":"2021","unstructured":"He ZH, et al. The molecular mechanism of LRP1 in physiological vascular homeostasis and signal transduction pathways. Biomed Pharmacother. 2021;139:111667.","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"1059_CR66","first-page":"581","volume":"19","author":"E Boscolo","year":"2007","unstructured":"Boscolo E, et al. \u03b2 amyloid angiogenic activity and. Int J Mol Med. 2007;19(4):581\u20137.","journal-title":"Int J Mol Med"},{"key":"1059_CR67","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.gene.2018.02.026","volume":"654","author":"B Lin","year":"2018","unstructured":"Lin B, et al. Anlotinib inhibits angiogenesis via suppressing the activation of VEGFR2, PDGFRbeta and FGFR1. Gene. 2018;654:77\u201386.","journal-title":"Gene"},{"issue":"5323","key":"1059_CR68","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1126\/science.277.5323.242","volume":"277","author":"P Lindahl","year":"1997","unstructured":"Lindahl P, et al. Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. Science. 1997;277(5323):242\u20135.","journal-title":"Science"},{"issue":"5","key":"1059_CR69","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1161\/ATVBAHA.107.161521","volume":"29","author":"K Gaengel","year":"2009","unstructured":"Gaengel K, et al. Endothelial-mural cell signaling in vascular development and angiogenesis. Arterioscler Thromb Vasc Biol. 2009;29(5):630\u20138.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"14","key":"1059_CR70","doi-asserted-by":"publisher","first-page":"3047","DOI":"10.1242\/dev.126.14.3047","volume":"126","author":"M Hellstrom","year":"1999","unstructured":"Hellstrom M, et al. Role of PDGF-B and PDGFR-beta in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse. Development. 1999;126(14):3047\u201355.","journal-title":"Development"},{"issue":"4","key":"1059_CR71","doi-asserted-by":"publisher","first-page":"589","DOI":"10.3390\/molecules22040589","volume":"22","author":"T Schumacher","year":"2017","unstructured":"Schumacher T, Benndorf RA. ABC Transport Proteins in Cardiovascular Disease-A Brief Summary. Molecules. 2017;22(4):589.","journal-title":"Molecules"},{"key":"1059_CR72","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1146\/annurev.physiol.62.1.79","volume":"62","author":"MV Cohen","year":"2000","unstructured":"Cohen MV, Baines CP, Downey JM. Ischemic preconditioning: from adenosine receptor to KATP channel. Annu Rev Physiol. 2000;62:79\u2013109.","journal-title":"Annu Rev Physiol"},{"issue":"2","key":"1059_CR73","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1172\/JCI0215672","volume":"110","author":"WA Chutkow","year":"2002","unstructured":"Chutkow WA, et al. Episodic coronary artery vasospasm and hypertension develop in the absence of Sur2 K(ATP) channels. J Clin Invest. 2002;110(2):203\u20138.","journal-title":"J Clin Invest"},{"issue":"6","key":"1059_CR74","doi-asserted-by":"publisher","first-page":"C1263","DOI":"10.1152\/ajpcell.1999.277.6.C1263","volume":"277","author":"C Kyriakides","year":"1999","unstructured":"Kyriakides C, et al. Skeletal muscle reperfusion injury is mediated by neutrophils and the complement membrane attack complex. Am J Physiol Cell Physiol. 1999;277(6):C1263\u20138.","journal-title":"Am J Physiol Cell Physiol"},{"issue":"22","key":"1059_CR75","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1161\/01.CIR.97.22.2259","volume":"97","author":"AP Vakeva","year":"1998","unstructured":"Vakeva AP, et al. Myocardial infarction and apoptosis after myocardial ischemia and reperfusion: role of the terminal complement components and inhibition by anti-C5 therapy. Circulation. 1998;97(22):2259\u201367.","journal-title":"Circulation"},{"issue":"4","key":"1059_CR76","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/S0167-5699(97)01243-7","volume":"19","author":"G Opdenakker","year":"1998","unstructured":"Opdenakker G, Fibbe WE, Van Damme J. The molecular basis of leukocytosis. Immunol Today. 1998;19(4):182\u20139.","journal-title":"Immunol Today"},{"issue":"16","key":"1059_CR77","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1016\/j.jacc.2020.02.058","volume":"75","author":"D Mart\u00ednez-L\u00f3pez","year":"2020","unstructured":"Mart\u00ednez-L\u00f3pez D, et al. Complement C5 Protein as a Marker of Subclinical Atherosclerosis. J Am Coll Cardiol. 2020;75(16):1926\u201341.","journal-title":"J Am Coll Cardiol"},{"key":"1059_CR78","doi-asserted-by":"publisher","first-page":"109441","DOI":"10.1016\/j.cellsig.2019.109441","volume":"66","author":"J Rong","year":"2020","unstructured":"Rong J, et al. Long non-coding RNA KCNQ1OT1\/microRNA-204-5p\/LGALS3 axis regulates myocardial ischemia\/reperfusion injury in mice. Cell Signal. 2020;66:109441.","journal-title":"Cell Signal"},{"issue":"18","key":"1059_CR79","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1161\/CIRCULATIONAHA.118.035047","volume":"138","author":"K Shirakawa","year":"2018","unstructured":"Shirakawa K, et al. IL (Interleukin)-10-STAT3-Galectin-3 Axis Is Essential for Osteopontin-Producing Reparative Macrophage Polarization After Myocardial Infarction. Circulation. 2018;138(18):2021\u201335.","journal-title":"Circulation"},{"key":"1059_CR80","doi-asserted-by":"publisher","first-page":"109816","DOI":"10.1016\/j.cellsig.2020.109816","volume":"77","author":"MJ Daseke 2nd","year":"2021","unstructured":"Daseke MJ 2nd, et al. Neutrophil signaling during myocardial infarction wound repair. Cell Signal. 2021;77:109816.","journal-title":"Cell Signal"},{"issue":"1","key":"1059_CR81","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.molimm.2012.11.006","volume":"55","author":"S Schmidt","year":"2013","unstructured":"Schmidt S, Moser M, Sperandio M. The molecular basis of leukocyte recruitment and its deficiencies. Mol Immunol. 2013;55(1):49\u201358.","journal-title":"Mol Immunol"},{"issue":"6","key":"1059_CR82","doi-asserted-by":"publisher","first-page":"892","DOI":"10.3390\/biom13060892","volume":"13","author":"HE Conley","year":"2023","unstructured":"Conley HE, Sheats MK. Targeting Neutrophil beta(2)-Integrins: A Review of Relevant Resources, Tools, and Methods. Biomolecules. 2023;13(6):892.","journal-title":"Biomolecules"},{"issue":"19","key":"1059_CR83","doi-asserted-by":"publisher","first-page":"3039","DOI":"10.3390\/cells11193039","volume":"11","author":"L Wen","year":"2022","unstructured":"Wen L, et al. Structural Basis of beta2 Integrin Inside-Out Activation. Cells. 2022;11(19):3039.","journal-title":"Cells"},{"key":"1059_CR84","doi-asserted-by":"publisher","first-page":"114827","DOI":"10.1016\/j.biopha.2023.114827","volume":"163","author":"H Tian","year":"2023","unstructured":"Tian H, et al. Abnormalities of glucose and lipid metabolism in myocardial ischemia-reperfusion injury. Biomed Pharmacother. 2023;163:114827.","journal-title":"Biomed Pharmacother"},{"issue":"6","key":"1059_CR85","doi-asserted-by":"publisher","first-page":"H1553","DOI":"10.1152\/ajpheart.00158.2018","volume":"315","author":"S Toldo","year":"2018","unstructured":"Toldo S, et al. Inflammasome, pyroptosis, and cytokines in myocardial ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol. 2018;315(6):H1553\u201368.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"4","key":"1059_CR86","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.7150\/thno.50905","volume":"11","author":"M Zhao","year":"2021","unstructured":"Zhao M, et al. Mitochondrial ROS promote mitochondrial dysfunction and inflammation in ischemic acute kidney injury by disrupting TFAM-mediated mtDNA maintenance. Theranostics. 2021;11(4):1845\u201363.","journal-title":"Theranostics"},{"issue":"4","key":"1059_CR87","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1038\/s41589-022-01224-y","volume":"19","author":"Y Guo","year":"2023","unstructured":"Guo Y, et al. Small molecule agonist of mitochondrial fusion repairs mitochondrial dysfunction. Nat Chem Biol. 2023;19(4):468\u201377.","journal-title":"Nat Chem Biol"},{"issue":"11","key":"1059_CR88","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1002\/acn3.51470","volume":"8","author":"O Hikmat","year":"2021","unstructured":"Hikmat O, et al. Expanding the phenotypic spectrum of BCS1L-related mitochondrial disease. Ann Clin Transl Neurol. 2021;8(11):2155\u201365.","journal-title":"Ann Clin Transl Neurol"},{"issue":"6","key":"1059_CR89","doi-asserted-by":"publisher","first-page":"858","DOI":"10.15252\/embr.201541612","volume":"17","author":"A Pagliuso","year":"2016","unstructured":"Pagliuso A, et al. A role for septin 2 in Drp1-mediated mitochondrial fission. EMBO Rep. 2016;17(6):858\u201373.","journal-title":"EMBO Rep"},{"issue":"1","key":"1059_CR90","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1186\/s40001-023-01180-w","volume":"28","author":"C Ye","year":"2023","unstructured":"Ye C, et al. Abnormal expression of fission and fusion genes and the morphology of mitochondria in eutopic and ectopic endometrium. Eur J Med Res. 2023;28(1):209.","journal-title":"Eur J Med Res"},{"issue":"3","key":"1059_CR91","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1111\/febs.14186","volume":"285","author":"A Pena-Blanco","year":"2018","unstructured":"Pena-Blanco A, Garcia-Saez AJ. Bax, Bak and beyond - mitochondrial performance in apoptosis. FEBS J. 2018;285(3):416\u201331.","journal-title":"FEBS J"},{"issue":"4","key":"1059_CR92","first-page":"68","volume":"9","author":"K Bajbouj","year":"2020","unstructured":"Bajbouj K, et al. Estrogen Signaling Induces Mitochondrial Dysfunction-Associated Autophagy and Senescence in Breast Cancer Cells. Biology (Basel). 2020;9(4):68.","journal-title":"Biology (Basel)"},{"issue":"6","key":"1059_CR93","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/j.bj.2021.11.012","volume":"45","author":"W Zhou","year":"2022","unstructured":"Zhou W, et al. AIFM1, negatively regulated by miR-145-5p, aggravates hypoxia-induced cardiomyocyte injury. Biomed J. 2022;45(6):870\u201382.","journal-title":"Biomed J"},{"issue":"35","key":"1059_CR94","doi-asserted-by":"publisher","first-page":"25207","DOI":"10.1074\/jbc.M113.489674","volume":"288","author":"Y Cho","year":"2013","unstructured":"Cho Y, et al. Peroxisome proliferator-activated receptor gamma coactivator 1 (PGC-1)- and estrogen-related receptor (ERR)-induced regulator in muscle 1 (Perm1) is a tissue-specific regulator of oxidative capacity in skeletal muscle cells. J Biol Chem. 2013;288(35):25207\u201318.","journal-title":"J Biol Chem"},{"issue":"1","key":"1059_CR95","doi-asserted-by":"publisher","first-page":"100825","DOI":"10.1016\/j.jbc.2021.100825","volume":"297","author":"Y Cho","year":"2021","unstructured":"Cho Y, et al. Perm1 promotes cardiomyocyte mitochondrial biogenesis and protects against hypoxia\/reoxygenation-induced damage in mice. J Biol Chem. 2021;297(1):100825.","journal-title":"J Biol Chem"},{"issue":"9\u201310","key":"1059_CR96","first-page":"453","volume":"57","author":"S Gawe\u0142","year":"2004","unstructured":"Gawe\u0142 S, et al. Malondialdehyde (MDA) as a lipid peroxidation marker. Wiad Lek. 2004;57(9\u201310):453\u20135.","journal-title":"Wiad Lek"},{"key":"1059_CR97","doi-asserted-by":"publisher","first-page":"0081","DOI":"10.1038\/s41551-017-0081","volume":"1","author":"RZ Lin","year":"2017","unstructured":"Lin RZ, et al. Host non-inflammatory neutrophils mediate the engraftment of bioengineered vascular networks. Nat Biomed Eng. 2017;1:0081.","journal-title":"Nat Biomed Eng"},{"issue":"3","key":"1059_CR98","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/ng1311","volume":"36","author":"A Helgadottir","year":"2004","unstructured":"Helgadottir A, et al. The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke. Nat Genet. 2004;36(3):233\u20139.","journal-title":"Nat Genet"},{"issue":"3\u20135","key":"1059_CR99","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/S0171-2985(11)80341-4","volume":"187","author":"PS Tobias","year":"1993","unstructured":"Tobias PS, Ulevitch RJ. Lipopolysaccharide binding protein and CD14 in LPS dependent macrophage activation. Immunobiology. 1993;187(3\u20135):227\u201332.","journal-title":"Immunobiology"},{"issue":"7","key":"1059_CR100","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1182\/blood-2016-11-749622","volume":"130","author":"R Pick","year":"2017","unstructured":"Pick R, et al. Coronin 1A, a novel player in integrin biology, controls neutrophil trafficking in innate immunity. Blood. 2017;130(7):847\u201358.","journal-title":"Blood"},{"issue":"8","key":"1059_CR101","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1038\/s41423-023-01057-2","volume":"20","author":"Y Chen","year":"2023","unstructured":"Chen Y, et al. Wip1 inhibits neutrophil extracellular traps to promote abscess formation in mice by directly dephosphorylating Coronin-1a. Cell Mol Immunol. 2023;20(8):941\u201354.","journal-title":"Cell Mol Immunol"},{"issue":"3","key":"1059_CR102","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/s41419-018-0378-3","volume":"9","author":"TT Tang","year":"2018","unstructured":"Tang TT, et al. Hydroxychloroquine attenuates renal ischemia\/reperfusion injury by inhibiting cathepsin mediated NLRP3 inflammasome activation. Cell Death Dis. 2018;9(3):351.","journal-title":"Cell Death Dis"},{"issue":"1","key":"1059_CR103","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1189\/jlb.3A0716-317RR","volume":"102","author":"ML Akenhead","year":"2017","unstructured":"Akenhead ML, et al. Fluid shear-induced cathepsin B release in the control of Mac1-dependent neutrophil adhesion. J Leukoc Biol. 2017;102(1):117\u201326.","journal-title":"J Leukoc Biol"},{"issue":"15","key":"1059_CR104","doi-asserted-by":"publisher","first-page":"e25553","DOI":"10.1097\/MD.0000000000025553","volume":"100","author":"S Guo","year":"2021","unstructured":"Guo S, et al. Identification and analysis of key genes associated with acute myocardial infarction by integrated bioinformatics methods. Medicine (Baltimore). 2021;100(15):e25553.","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"1059_CR105","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.amjcard.2004.10.009","volume":"95","author":"J Nijm","year":"2005","unstructured":"Nijm J, et al. Circulating levels of proinflammatory cytokines and neutrophil-platelet aggregates in patients with coronary artery disease. Am J Cardiol. 2005;95(4):452\u20136.","journal-title":"Am J Cardiol"},{"issue":"11","key":"1059_CR106","doi-asserted-by":"publisher","first-page":"e0260442","DOI":"10.1371\/journal.pone.0260442","volume":"16","author":"R Guan","year":"2021","unstructured":"Guan R, et al. Plasma obtained following murine hindlimb ischemic conditioning protects against oxidative stress in zebrafish models through activation of nrf2a and downregulation of duox. Plos One. 2021;16(11):e0260442.","journal-title":"Plos One"},{"issue":"21","key":"1059_CR107","doi-asserted-by":"publisher","first-page":"8616","DOI":"10.1074\/jbc.M116.768309","volume":"292","author":"LD Healy","year":"2017","unstructured":"Healy LD, et al. Activated protein C inhibits neutrophil extracellular trap formation in vitro and activation in vivo. J Biol Chem. 2017;292(21):8616\u201329.","journal-title":"J Biol Chem"},{"issue":"4","key":"1059_CR108","doi-asserted-by":"publisher","first-page":"613","DOI":"10.3892\/etm.2022.11550","volume":"24","author":"G Cheng","year":"2022","unstructured":"Cheng G, et al. TIPE2 protects cardiomyocytes from ischemia-reperfusion-induced apoptosis by decreasing cell autophagy via the mTORC1 signaling pathway. Exp Ther Med. 2022;24(4):613.","journal-title":"Exp Ther Med"},{"key":"1059_CR109","doi-asserted-by":"publisher","first-page":"15014","DOI":"10.1038\/cddiscovery.2015.14","volume":"1","author":"MM Rashid","year":"2015","unstructured":"Rashid MM, et al. Muscle LIM protein\/CSRP3: a mechanosensor with a role in autophagy. Cell Death Discov. 2015;1:15014.","journal-title":"Cell Death Discov"},{"issue":"3","key":"1059_CR110","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s00441-006-0376-0","volume":"328","author":"Y Tajika","year":"2007","unstructured":"Tajika Y, et al. VAMP2 is expressed in muscle satellite cells and up-regulated during muscle regeneration. Cell Tissue Res. 2007;328(3):573\u201381.","journal-title":"Cell Tissue Res"},{"issue":"3","key":"1059_CR111","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1111\/j.1600-0854.2003.00164.x","volume":"5","author":"MC Towler","year":"2004","unstructured":"Towler MC, Kaufman SJ, Brodsky FM. Membrane traffic in skeletal muscle. Traffic. 2004;5(3):129\u201339.","journal-title":"Traffic"},{"issue":"2","key":"1059_CR112","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1002\/j.1460-2075.1989.tb03388.x","volume":"8","author":"M Baumert","year":"1989","unstructured":"Baumert M, et al. Synaptobrevin: an integral membrane protein of 18,000 daltons present in small synaptic vesicles of rat brain. EMBO J. 1989;8(2):379\u201384.","journal-title":"EMBO J"},{"issue":"1","key":"1059_CR113","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s40169-016-0114-5","volume":"5","author":"D Kitzenberg","year":"2016","unstructured":"Kitzenberg D, Colgan SP, Glover LE. Creatine kinase in ischemic and inflammatory disorders. Clin Transl Med. 2016;5(1):31.","journal-title":"Clin Transl Med"},{"issue":"1","key":"1059_CR114","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/acel.12538","volume":"16","author":"A Ansari","year":"2017","unstructured":"Ansari A, et al. Function of the SIRT3 mitochondrial deacetylase in cellular physiology, cancer, and neurodegenerative disease. Aging Cell. 2017;16(1):4\u201316.","journal-title":"Aging Cell"},{"issue":"D1","key":"1059_CR115","doi-asserted-by":"publisher","first-page":"D442","DOI":"10.1093\/nar\/gky1106","volume":"47","author":"Y Perez-Riverol","year":"2019","unstructured":"Perez-Riverol Y, et al. The PRIDE database and related tools and resources in 2019: improving support for quantification data. Nucleic Acids Res. 2019;47(D1):D442\u201350.","journal-title":"Nucleic Acids Res"}],"container-title":["Journal of Biomedical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12929-024-01059-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12929-024-01059-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12929-024-01059-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T04:05:53Z","timestamp":1721016353000},"score":1,"resource":{"primary":{"URL":"https:\/\/jbiomedsci.biomedcentral.com\/articles\/10.1186\/s12929-024-01059-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,15]]},"references-count":115,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1059"],"URL":"https:\/\/doi.org\/10.1186\/s12929-024-01059-w","relation":{},"ISSN":["1423-0127"],"issn-type":[{"value":"1423-0127","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,15]]},"assertion":[{"value":"8 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Human cell donors provided informed consent prior to sample collection. This study was approved by the Andalusian Bioethics Committee for Biomedical Research, Consejeria de Salud, (registration number 119.21), and it followed the principles outlined in the Declaration of Helsinki. Additionally, Animal experiments were approved by the Ethical committee of the University of Cadiz, as well as the Andalusian Committee of animal experimentation (reference number 25\/01\/2022\/006). This study followed the standard guidelines for animal research included in the Spanish laws composed of the RD 53\/2013 as well as the European Regulations (2020\/569\/EU).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The manuscript does not contain any personal data and therefore does not require any individual\u00b4s consent for publication. All authors have provided their consent to publish this work, and they have reviewed and approved the final published version.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"71"}}